Review article · 2021 · Open access

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Henrik Zetterberg, Kaj Blennow

Molecular Neurodegeneration, 16(1), 10 · Published 19 February 2021 · DOI 10.1186/s13024-021-00430-x

Open PDFView at the publisherCite this paper

In brief

“Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics” is a 2021 review article by Henrik Zetterberg and Kaj Blennow, published in Molecular Neurodegeneration. OpenAlex counts 241 citations as of 18 November 2026, which puts it in the top 1% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular Neurodegeneration.

Citations
241
Most cited in
2022 (51)
Field-weighted impact
4.88
References
64
Authors
2

Abstract

Four fluid-based biomarkers have been developed into diagnostic tests for Alzheimer's disease (AD) pathology: the ratio of 42 to 40 amino acid-long amyloid β, a marker of plaque pathology; total-tau and phosphorylated tau, markers of AD-related changes in tau metabolism and secretion; and neurofilament light, a marker of neurodegeneration. When measured in cerebrospinal fluid, these biomarkers can be used in clinical practice to support a diagnosis of mild cognitive impairment or dementia due to AD. Recently, technological breakthroughs have made it possible to measure them in standard blood samples as well. Here, we give an updated account of the current state of the fluid-based AD biomarker research field. We discuss how the new blood tests may be used in research and clinical practice, and what role they may play in relation to more established diagnostic tests, such as CSF biomarkers and amyloid and tau positron emission tomography, to facilitate the effective implementation of future disease-modifying therapies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zetterberg, H., & Blennow, K. (2021). Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics. Molecular Neurodegeneration, 16(1), 10. https://doi.org/10.1186/s13024-021-00430-x

MLA 9

Zetterberg, Henrik, and Kaj Blennow. “Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics.” Molecular Neurodegeneration, vol. 16, no. 1, 2021, p. 10. https://doi.org/10.1186/s13024-021-00430-x.

Chicago

Zetterberg, Henrik and Kaj Blennow. 2021. “Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics.” Molecular Neurodegeneration 16 (1): 10. https://doi.org/10.1186/s13024-021-00430-x.

Harvard

Zetterberg, H. and Blennow, K. (2021) ‘Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics’, Molecular Neurodegeneration, 16(1), p. 10. doi:10.1186/s13024-021-00430-x.

IEEE

H. Zetterberg and K. Blennow, “Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics,” Molecular Neurodegeneration, vol. 16, no. 1, p. 10, 2021, doi: 10.1186/s13024-021-00430-x.

BibTeX

@article{zetterberg2021moving,
  title     = {{Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics}},
  author    = {Zetterberg, Henrik and Blennow, Kaj},
  journal   = {Molecular Neurodegeneration},
  year      = {2021},
  volume    = {16},
  number    = {1},
  pages     = {10},
  doi       = {10.1186/s13024-021-00430-x},
  url       = {https://doi.org/10.1186/s13024-021-00430-x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20211818
20225151
20233434
20244242
20255050
20264646

Its field-weighted citation impact is 4.88: it has been cited 4.88 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • Alzheimer's disease
  • fluid biomarkers
  • amyloid-beta 42/40 ratio
  • total tau
  • phosphorylated tau
  • neurofilament light chain
  • cerebrospinal fluid biomarkers
  • blood-based biomarkers

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Zetterberg, H., & Blennow, K. (2021). Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics. Molecular Neurodegeneration, 16(1), 10. https://doi.org/10.1186/s13024-021-00430-x

How many times has this paper been cited?

241 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular Neurodegeneration: sign in and open the PDF from this page.

Who wrote this paper?

Henrik Zetterberg, Kaj Blennow.

What is the DOI of this paper?

10.1186/s13024-021-00430-x, permanently at https://doi.org/10.1186/s13024-021-00430-x. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.